Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Journal of Virology
|
June 22, 2007
Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion
Austin N Kirschner, Amanda S Lowrey, Richard Longnecker, et al.
Virus Genes
|
February 18, 2010
Characteristics of Epstein-Barr virus envelope protein gp42
Pamela L Shaw, Austin N Kirschner, Theodore S Jardetzky, et al.
Plos One
|
April 2, 2019
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway
Konjeti R Sekhar, Jian Wang, Michael L Freeman, et al.
Journal of Virology
|
July 30, 2010
Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays
Fengling Liu, Gaby Marquardt, Austin N Kirschner, et al.
Journal of Virology
|
September 16, 2006
Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion
Austin N Kirschner, Jasmina Omerovic, Boris Popov, et al.
World Journal of Clinical Oncology
|
January 10, 2019
Radiation-associated epithelial-myoepithelial carcinoma among five secondary malignancies: A case report and review of literature
Mohamed H Khattab, Alexander D Sherry, Carolyn G Ahlers, et al.
Journal of Contemporary Brachytherapy
|
May 3, 2014
Multisector dosimetry in the immediate post-implant period: significant under dosage of the prostate base
Austin N Kirschner, Vythialingam Sathiaseelan, Yunkai Zhang, et al.
American Journal of Clinical Oncology
|
November 22, 2022
Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases
Austin P H Dove, Alex Wells, Wu Gong, et al.
American Journal of Clinical Oncology
|
September 20, 2011
Trends in the use of postoperative radiation therapy in patients with localized resectable pancreatic cancer
Eric T Shinohara, Nandita Mitra, Wan Fei, et al.
BJU International
|
March 24, 2023
Intravesical oncolytic virotherapy and immunotherapy for non-muscle-invasive bladder cancer mouse model
Woodson W Smelser, Jian Wang, Kristen M Ogden, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Journal of Virology
|
June 22, 2007
Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion
Austin N Kirschner, Amanda S Lowrey, Richard Longnecker, et al.
Virus Genes
|
February 18, 2010
Characteristics of Epstein-Barr virus envelope protein gp42
Pamela L Shaw, Austin N Kirschner, Theodore S Jardetzky, et al.
Plos One
|
April 2, 2019
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway
Konjeti R Sekhar, Jian Wang, Michael L Freeman, et al.
Journal of Virology
|
July 30, 2010
Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays
Fengling Liu, Gaby Marquardt, Austin N Kirschner, et al.
Journal of Virology
|
September 16, 2006
Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion
Austin N Kirschner, Jasmina Omerovic, Boris Popov, et al.
World Journal of Clinical Oncology
|
January 10, 2019
Radiation-associated epithelial-myoepithelial carcinoma among five secondary malignancies: A case report and review of literature
Mohamed H Khattab, Alexander D Sherry, Carolyn G Ahlers, et al.
Journal of Contemporary Brachytherapy
|
May 3, 2014
Multisector dosimetry in the immediate post-implant period: significant under dosage of the prostate base
Austin N Kirschner, Vythialingam Sathiaseelan, Yunkai Zhang, et al.
American Journal of Clinical Oncology
|
November 22, 2022
Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases
Austin P H Dove, Alex Wells, Wu Gong, et al.
American Journal of Clinical Oncology
|
September 20, 2011
Trends in the use of postoperative radiation therapy in patients with localized resectable pancreatic cancer
Eric T Shinohara, Nandita Mitra, Wan Fei, et al.
BJU International
|
March 24, 2023
Intravesical oncolytic virotherapy and immunotherapy for non-muscle-invasive bladder cancer mouse model
Woodson W Smelser, Jian Wang, Kristen M Ogden, et al.
Page
of 5